| CAS NO: | 143388-64-1 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 1g | 电议 |
| 2g | 电议 |
| Molecular Weight (MW) | 371.93 |
|---|---|
| Formula | C17H25N3O2S.HCl |
| CAS No. | 143388-64-1 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 74 mg/mL (199.0 mM) |
| Water: 22 mg/mL (59.2 mM) | |
| Ethanol: <1 mg/mL | |
| Other info | Chemical Name: N-Methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide hydrochloride InChi Key: AWEZYKMQFAUBTD-UHFFFAOYSA-N InChi Code: InChI=1S/C17H25N3O2S.ClH/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14;/h3-4,11-12,14,18-19H,5-10H2,1-2H3;1H SMILES Code: CN1CCC(C2=CNC3=C2C=C(CCS(=O)(NC)=O)C=C3)CC1.[H]Cl |
| Synonyms | GR-85548A; Naratriptan HCl; Naratriptan Hydrochloride; GR 85548A; GR85548A; Amerge; Naramig; |
| In Vitro | In vitro activity: Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light. |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References | Cephalalgia. 1997 May;17(3):145-52. |
m.cnreagent.com